Geode Capital Management LLC Buys 50,579 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN)

Geode Capital Management LLC boosted its stake in Design Therapeutics, Inc. (NASDAQ:DSGN) by 7.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 758,550 shares of the company’s stock after buying an additional 50,579 shares during the quarter. Geode Capital Management LLC owned approximately 1.34% of Design Therapeutics worth $4,081,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the stock. Paloma Partners Management Co purchased a new stake in shares of Design Therapeutics in the third quarter valued at about $64,000. SG Americas Securities LLC bought a new position in shares of Design Therapeutics in the third quarter valued at approximately $66,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Design Therapeutics during the third quarter valued at approximately $71,000. MetLife Investment Management LLC bought a new position in Design Therapeutics in the 3rd quarter valued at $104,000. Finally, American Century Companies Inc. bought a new stake in shares of Design Therapeutics during the 2nd quarter worth $71,000. 56.64% of the stock is currently owned by institutional investors.

Design Therapeutics Stock Performance

Shares of NASDAQ:DSGN opened at $6.66 on Monday. The company has a market capitalization of $377.10 million, a P/E ratio of -7.84 and a beta of 1.86. Design Therapeutics, Inc. has a fifty-two week low of $2.24 and a fifty-two week high of $7.77. The company’s 50-day moving average is $6.05 and its 200 day moving average is $5.17.

About Design Therapeutics

Design Therapeutics, Inc a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion.